Human CLP1 Mutations Alter tRNA Biogenesis, Affecting Both Peripheral and Central Nervous System Function

dc.authorid0000-0003-1623-3303
dc.authorid0000-0003-1582-6924
dc.authorid0000-0002-2432-9279
dc.authorid0000-0002-0941-4571
dc.authorid0000-0002-4667-3679
dc.authorid0000-0002-4336-6518
dc.authorid0000-0002-3749-2884
dc.contributor.authorKaraca, Ender
dc.contributor.authorWeitzer, Stefan
dc.contributor.authorPehlivan, Davut
dc.contributor.authorShiraishi, Hiroshi
dc.contributor.authorGogakos, Tasos
dc.contributor.authorHanada, Toshikatsu
dc.contributor.authorJhangiani, Shalini N.
dc.date.accessioned2025-05-10T19:48:49Z
dc.date.issued2014
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractCLP1 is a RNA kinase involved in tRNA splicing. Recently, CLP1 kinase-dead mice were shown to display a neuromuscular disorder with loss of motor neurons and muscle paralysis. Human genome analyses now identified a CLP1 homozygous missense mutation (p. R140H) in five unrelated families, leading to a loss of CLP1 interaction with the tRNA splicing endonuclease (TSEN) complex, largely reduced pretRNA cleavage activity, and accumulation of linear tRNA introns. The affected individuals develop severe motor-sensory defects, cortical dysgenesis, and microcephaly. Mice carrying kinase-dead CLP1 also displayed microcephaly and reduced cortical brain volume due to the enhanced cell death of neuronal progenitors that is associated with reduced numbers of cortical neurons. Our data elucidate a neurological syndrome defined by CLP1 mutations that impair tRNA splicing. Reduction of a founder mutation to homozygosity illustrates the importance of rare variations in disease and supports the clan genomics hypothesis.
dc.description.sponsorshipUS National Institute of Neurological Disorders and Stroke (NINDS) [R01NS058529]; US National Human Genome Research Institute (NHGRI) [U54HG006542]; Astellas Foundation for Research on Metabolic Disorders and The Mochida Memorial Foundation for Medical and Pharmaceutical Research; NINDS [K23NS078056]; DFG [FG885, GRK 1459]; IMBA; Advanced ERC grant; NIAID [1K23AI087821- 01]; Grants-in-Aid for Scientific Research [25460387] Funding Source: KAKEN
dc.description.sponsorshipWe thank the patients and families who participated in this study. We thank the CSF/PIF MRI imaging facility at the campus Vienna BioCenter. This work was supported in part by US National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS058529 and US National Human Genome Research Institute (NHGRI) grant U54HG006542 to J.R.L.H.S. is supported in part by the fellowship of Astellas Foundation for Research on Metabolic Disorders and The Mochida Memorial Foundation for Medical and Pharmaceutical Research. W.W. is supported by a K23NS078056 grant from the NINDS. M.G. is supported by grants from the DFG (FG885 and GRK 1459). J.M. and S.W. are supported by IMBA. J.M.P. is supported by an Advanced ERC grant and IMBA. L.M.F. is supported by a Career Development Award (1K23AI087821- 01) from the NIAID. J.R.L. is a paid consultant for Athena Diagnostics, has stock ownership in 23andMe and Ion Torrent Systems, and is a coinventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the clinical exome sequencing offered in the Medical Genetics Laboratory.
dc.identifier.doi10.1016/j.cell.2014.02.058
dc.identifier.endpage650
dc.identifier.issn0092-8674
dc.identifier.issn1097-4172
dc.identifier.issue3
dc.identifier.pmid24766809
dc.identifier.scopus2-s2.0-84899576549
dc.identifier.scopusqualityQ1
dc.identifier.startpage636
dc.identifier.urihttps://doi.org/10.1016/j.cell.2014.02.058
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11827
dc.identifier.volume157
dc.identifier.wosWOS:000335392100013
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherCell Press
dc.relation.ispartofCell
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectCause Pontocerebellar Hypoplasia
dc.subjectSynthetase Mutations
dc.subjectProtein Function
dc.subjectGene
dc.subjectDisease
dc.subjectNeuropathy
dc.subjectComplex
dc.titleHuman CLP1 Mutations Alter tRNA Biogenesis, Affecting Both Peripheral and Central Nervous System Function
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
11827.pdf
Boyut:
4.56 MB
Biçim:
Adobe Portable Document Format